Annals of Surgical Oncology

, Volume 12, Issue 8, pp 575–578 | Cite as

In-Transit Recurrence After Sentinel Lymph NodeBiopsy in Melanoma: Primum Non Nocere



Sentinel Lymph Node Sentinel Lymph Node Biopsy Wide Excision Positive Sentinel Node Completion Lymph Node Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative mapping for early stage melanoma. Arch Surg 1992;127:392–9Google Scholar
  2. 2.
    Balch CM, Soong SJ, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1–4 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87–97Google Scholar
  3. 3.
    Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999;189:195–204Google Scholar
  4. 4.
    Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–83Google Scholar
  5. 5.
    Wheatley K, Ives N, Hancock B. Does adjuvant interferon-alfa for high risk melanoma provide a worthwhile benefit? A meta-analysis of the randomized trials. Cancer Treat Rev 2003;29:241–52Google Scholar
  6. 6.
    Houghton AN, Coit DG, Chu D, et al. Melanoma clinical practice guidelines in oncology. J Natl Comprehensive Cancer Network 2004;2:46–60Google Scholar
  7. 7.
    Medalie N, Ackerman AB. Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now. Br J Dermatol 2004;151:298–307Google Scholar
  8. 8.
    Wrightson WR, Wong SL, Edwards MJ, et al. Complication associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003;10:676–80Google Scholar
  9. 9.
    Roaten JB, Pearlman N, Gonzalez R, et al. Identifying risk factors for complications following sentinel lymph node biopsy for melanoma. Arch Surg 2005;140:85–9Google Scholar
  10. 10.
    Estourgie SH, Nieweg OE, Kroon BBR. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 2004;91:1370–1Google Scholar
  11. 11.
    Thomas JM, Clark MA. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 2004;30:686–91Google Scholar
  12. 12.
    Pawlik TM, Ross MI, Johnson MM, et al. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol (in press)Google Scholar
  13. 13.
    van Poll D, Thompson JF, Colman MH, et al. A sentinel node biopsy procedure does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Ann Surg Oncol (in press)Google Scholar
  14. 14.
    Lee JH, Essner R, Torisu-Itakura L, et al. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 2004;22:3677–84Google Scholar
  15. 15.
    Reeves ME, Delgado R, Busam KJ, et al. Prediction of nonsentinel node status in melanoma. Ann Surg Oncol 2003;10:27–31Google Scholar
  16. 16.
    Shivers SC, Wang X, Li W, et al. Molecular staging of melanoma: correlation with clinical outcome. JAMA 1998;280:1410–5Google Scholar
  17. 17.
    Goydos JS, Patel KN, Shih WJ, et al. Patterns of recurrence in patients with histologically negative but RT-PCR positive sentinel lymph nodes. J Am Coll Surg 2003;196:196–204Google Scholar
  18. 18.
    Kammula US, Ghossein R, Bhattacharya S, Coit DG. Serial followup and prognostic significance of reverse transcriptase polymerase chain reaction staged sentinel lymph nodes from melanoma patients. J Clin Oncol 2004;22:3989–96Google Scholar
  19. 19.
    Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999;17:3238–44Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2005

Authors and Affiliations

  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew York

Personalised recommendations